Methods of CD40 and toll like receptor immune activation
US12171803B2 · kind B2 · utility
0Cited by
5References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 11, 2018 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Oct 29, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of a TLR agonist and a chimeric CD154 polypeptide. Also provided herein are methods of enhanced immune function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.